Transactions
Questcor Pharmaceuticals acquired the rights to Doral from MedPointe
May. 2006
Client: Questcor Pharmaceuticals is a leading specialty / rare disease pharmaceutical company. Its lead product is Acthar Gel.
Role: Edgemont Partners acted as exclusive financial advisor to Questcor Pharmaceuticals in its acquisition of Doral from Medpointe Pharmaceuticals
Location: Hayward, CA
Sector: Pharmaceutical Services
Lead Banker: David Blume
acquired the rights to Doral from
